AHL
AMRX icon

Abel Hall LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Abel Hall LLC’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Sell
10,530
-8,772
-45% -$118K 0.03% 671
2025
Q4 		$243K Buy
+19,302
New +$221K 0.06% 445

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Abel Hall LLC's AMRX Position: Q1 2026 in Review

Abel Hall LLC reduced its Amneal Pharmaceuticals (AMRX) stake by 45% in Q1 2026, selling an estimated $118K and leaving 10,530 shares worth $131K. The position accounts for 0.03% of the portfolio, ranked #671.

Abel Hall LLC first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $243K in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Abel Hall LLC held 10,530 shares of Amneal Pharmaceuticals worth $131K as of Q1 2026.
  • Abel Hall LLC sold 8,772 Amneal Pharmaceuticals shares in Q1 2026, an estimated $118K.
  • Amneal Pharmaceuticals made up 0.03% of Abel Hall LLC's portfolio in Q1 2026, its #671 holding.
  • Abel Hall LLC first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Abel Hall LLC's Amneal Pharmaceuticals position peaked at $243K in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.